ConductScience.org, home

Paper938024

Ototoxicity of amikacin.

Black RE and 4 others. Antimicrob Agents Chemother, 1976. Cited by 138 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Ototoxicity of amikacin. Papers, record 938024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/938024

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ototoxicity of amikacin.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
138
iCite
Relative citation ratio, by iCite
7.15
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Black RER E
2Lau WKW K
3Weinstein RJR J
4Young LSL S
5Hewitt WLW L

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmikacinMajor topic
Hearing DisordersMajor topic
KanamycinMajor topic
Cochlea
Hearing Tests
Humans
Risk

Source PubMed

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113,825,416Kanamycin. II. Ototoxicity.Am Rev Respir Dis1960https://conductscience.org/library/papers/13825416PubMed
24,208,506Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4208506PubMed
34,544,451Ototoxicity studies with BB-K8, a new semisynthetic aminoglycoside antibiotic.J Antibiot (Tokyo)1973https://conductscience.org/library/papers/4544451PubMed
44,486,599Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside.J Antibiot (Tokyo)1972https://conductscience.org/library/papers/4486599PubMed
54,462,465Pharmacology of amikacin in humans.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4462465PubMed
64,790,604Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790604PubMed
74,793,881Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4793881PubMed
84,790,938In vitro studies of BB-K8, a new aminoglycoside antibiotic.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790938PubMed
91,097,551Radioimmunoassay, acetylating radio-enzymatic assay, and microbioassay of gentamicin: a comparative study.J Lab Clin Med1975https://conductscience.org/library/papers/1097551PubMed
101,200,524Amikacin therapy for serious gram-negative bacillary infections.Ann Intern Med1975https://conductscience.org/library/papers/1200524PubMed
115,227,783Toxicity of kanamycin in adults.Ann N Y Acad Sci1966https://conductscience.org/library/papers/5227783PubMed

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.

PMIDTitleJournalYearIn PapersSource
42,211,500Comedication that increase the risk of cisplatin-induced hearing loss in pediatric cancer patients: a narrative literature review and meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42211500PubMed
39,977,423Mycetoma managment: Therapeutic challenges and the role of pharmacovigilance.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/39977423PubMed
38,663,898Actinomycetoma in a patient with pre-existing sensorineural hearing loss: a linezolid-based treatment paradigm.BMJ Case Rep2024https://conductscience.org/library/papers/38663898PubMed
38,500,260The Use of Xenonucleic Acids Significantly Reduces the In Vivo Drift of Electrochemical Aptamer-Based Sensors.Angew Chem Int Ed Engl2024https://conductscience.org/library/papers/38500260PubMed
35,734,010Hearing aid support for patients with DR-TB in Ethiopia.Public Health Action2022https://conductscience.org/library/papers/35734010PubMed
35,423,693A wrinkled structure of gold film greatly improves the signaling of electrochemical aptamer-based biosensors.RSC Adv2020https://conductscience.org/library/papers/35423693PubMed
35,280,037Hearing screening outcomes in pediatric critical care survivors: a 1-year report.Acute Crit Care2022https://conductscience.org/library/papers/35280037PubMed
34,827,790Evidence of Hearing Loss and Unrelated Toxoplasmosis in a Free-Ranging Harbour Porpoise (Phocoena phocoena).Animals (Basel)2021https://conductscience.org/library/papers/34827790PubMed
30,948,747Area-dependent change of response in the rat's inferior colliculus to intracochlear electrical stimulation following neonatal cochlear damage.Sci Rep2019https://conductscience.org/library/papers/30948747PubMed
30,158,267Unusual discovery of a vestibular schwannoma following eradication therapy for Mycobacterium abscessus.BMJ Case Rep2018https://conductscience.org/library/papers/30158267PubMed
29,404,977Drug-Induced Ototoxicity: Diagnosis and Monitoring.Drug Saf2018https://conductscience.org/library/papers/29404977PubMed
28,165,504Implementation of a method to visualize noise-induced hearing loss in mass stranded cetaceans.Sci Rep2017https://conductscience.org/library/papers/28165504PubMed
28,012,509Changes in the inner ear structures in cystic fibrosis patients.Int J Pediatr Otorhinolaryngol2017https://conductscience.org/library/papers/28012509PubMed
26,654,443Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.BMC Pharmacol Toxicol2015https://conductscience.org/library/papers/26654443PubMed
26,248,372Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26248372PubMed
26,168,747A meta-analysis and systematic review of the prevalence of mitochondrially encoded 12S RNA in the general population: Is there a role for screening neonates requiring aminoglycosides?Afr J Paediatr Surg2015https://conductscience.org/library/papers/26168747PubMed
25,330,342Mycetoma medical therapy.PLoS Negl Trop Dis2014https://conductscience.org/library/papers/25330342PubMed
25,300,708Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.BMC Infect Dis2014https://conductscience.org/library/papers/25300708PubMed
24,250,429The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients.Iran J Pharm Res2011https://conductscience.org/library/papers/24250429PubMed
23,055,904Use of ototoxic medications in neonates-the need for follow-up hearing test.J Pediatr Pharmacol Ther2009https://conductscience.org/library/papers/23055904PubMed

See all 37 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/938024

GET https://conductscience.org/api/papers/v1/938024/cited_by?page=2